Stephanie Okey, Director: Crinetics Pharmaceuticals CRNX Sell · Filed 06/18

Trade details

Type: Insider sale
Amount: $224,121.04
Shares · price: 6,292 sh · $35.62 a share
Held after: 7,008 sh
Stock: Crinetics Pharmaceuticals CRNX
Person: Stephanie OkeyDirector
Trade date: 26/06/17
Filed: 26/06/18
Days to filing: 1 days

Sold 47.3% of holdings

Share of holding sold: 47.3%

Crinetics Pharmaceuticals trades, last 26 weeks

What else happened in Crinetics Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Stephanie Okey's recent trades

Stephanie OkeyDirector
Sell10b5-1 planCrinetics Pharmaceuticals
Sell10b5-1 plan
Crinetics Pharmaceuticals
CRNX
$22K
608 sh
$22K
Filed 06/18
Traded 06/17
Stephanie OkeyDirector
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$980K
14,000 sh
$980K
Filed 03/12
Traded 03/10
Stephanie OkeyDirector
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$81.7K
1,167 sh
$81.7K
Filed 03/12
Traded 03/10
Stephanie OkeyDirector
Planned sale10b5-1 planPTC Therapeutics
Planned sale10b5-1 plan
PTC Therapeutics
PTCT
$1.1M
15,167 sh
$1.1M
Filed 03/10
Traded 03/10
Stephanie OkeyDirector
Sell10b5-1 planPTC Therapeutics
Sell10b5-1 plan
PTC Therapeutics
PTCT
$401.4K
6,333 sh
$401.4K
Filed 03/09
Traded 03/05

Stephanie Okey, Director — sold $224.1K of Crinetics Pharmaceuticals CRNX · 47.3% of holdings · 10b5-1 plan | Whalegun